Combined MAPK Pathway and HDAC Inhibition Breaks Melanoma

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-19-0069
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation

Molecular Cancer Therapeutics
Cancer ResearchOncology
2017English

Effective Treatment of Metastatic Melanoma by Combining MAPK and PI3K Signaling Pathway Inhibitors

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

ATXN1L, CIC, and ETS Transcription Factors Modulate Sensitivity to MAPK Pathway Inhibition

Cell Reports
BiochemistryGeneticsMolecular Biology
2017English

Inhibition of MAPK/ERK Pathway Promotes Oligodendrocytes Generation and Recovery of Demyelinating Diseases

GLIA
Molecular NeuroscienceNeurologyCellular
2019English

809 Pou4f1 Promotes Braf Inhibitor Resistance by Reactivating Mapk Signaling Pathway in Melanoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

False HDAC Inhibition by Aurone Compound

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
2016English

Correction: ER Translocation of the MAPK Pathway Drives Therapy Resistance in BRAF-Mutant Melanoma

Cancer Discovery
Oncology
2019English

Inhibition of Smooth Muscle Cell Proliferation by Ezetimibe via the Cyclin D1-Mapk Pathway

Journal of Pharmacological Sciences
Molecular MedicinePharmacology
2014English

Inhibition of Siah2 Ubiquitin Ligase by Vitamin K3 (Menadione) Attenuates Hypoxia and MAPK Signaling and Blocks Melanoma Tumorigenesis

Pigment Cell and Melanoma Research
BiochemistryDermatologyOncologyGeneticsMolecular Biology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy